Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Skin Microbiome and Disease Severity in Infants With AD
In infants with atopic dermatitis (AD), a reduction in the abundance of Staphylococcus and an increase in that of skin microflora were associated with treatment and clinical improvement, a new study found. Researchers analyzed the association of skin microfloral dynamics with disease severity and treatment of AD in infants 0-1 years of age. Based on the eczema area and severity index, participants were divided into 5 groups: mild, moderate, severe, and severe post-treatment, with a healthy control group. Bacterial density at the perioral lesion, disease severity, and treatment were assessed in this population. They found:
- The perioral lesions were colonized predominantly by Firmicutes, followed in abundance by Proteobacteria, Actinobacteria, and Bacteroidetes.
- In infants with AD, the abundance of Bacteroidetes and Fusobacterium decreased significantly with an increase in disease severity.
- The abundance of 6 genera, including Prevotella, decreased significantly with an increase in disease severity.
- Skin bacterial composition varied with AD severity.
Zheng Y, et al. Alterations in the skin microbiome are associated with disease severity and treatment in the perioral zone of the skin of infants with atopic dermatitis. [Published online ahead of print May 31, 2019]. Eur J Clin Microbiol Infect Dis. doi: 0.1007/s10096-019-03598-9.